By -

Why the EpiPen Monopoly Will Continue: Exploring Alternatives

Epigate has captured America’s attention this summer. I desperately hope that once the EpiPen debacle has faded into the background that our country is still discussing – and making moves toward – fixing the broken system that brings us pharma price hike scandals at minimum once per year. In the meantime, after my review of...